These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

288 related items for PubMed ID: 28600641

  • 1. Predicting Deletion of Chromosomal Arms 1p/19q in Low-Grade Gliomas from MR Images Using Machine Intelligence.
    Akkus Z, Ali I, Sedlář J, Agrawal JP, Parney IF, Giannini C, Erickson BJ.
    J Digit Imaging; 2017 Aug; 30(4):469-476. PubMed ID: 28600641
    [Abstract] [Full Text] [Related]

  • 2. Predicting the 1p/19q Codeletion Status of Presumed Low-Grade Glioma with an Externally Validated Machine Learning Algorithm.
    van der Voort SR, Incekara F, Wijnenga MMJ, Kapas G, Gardeniers M, Schouten JW, Starmans MPA, Nandoe Tewarie R, Lycklama GJ, French PJ, Dubbink HJ, van den Bent MJ, Vincent AJPE, Niessen WJ, Klein S, Smits M.
    Clin Cancer Res; 2019 Dec 15; 25(24):7455-7462. PubMed ID: 31548344
    [Abstract] [Full Text] [Related]

  • 3. Radiogenomics of lower-grade gliomas: machine learning-based MRI texture analysis for predicting 1p/19q codeletion status.
    Kocak B, Durmaz ES, Ates E, Sel I, Turgut Gunes S, Kaya OK, Zeynalova A, Kilickesmez O.
    Eur Radiol; 2020 Feb 15; 30(2):877-886. PubMed ID: 31691122
    [Abstract] [Full Text] [Related]

  • 4. Impact of gross total resection in patients with WHO grade III glioma harboring the IDH 1/2 mutation without the 1p/19q co-deletion.
    Kawaguchi T, Sonoda Y, Shibahara I, Saito R, Kanamori M, Kumabe T, Tominaga T.
    J Neurooncol; 2016 Sep 15; 129(3):505-514. PubMed ID: 27401154
    [Abstract] [Full Text] [Related]

  • 5. The T2-FLAIR-mismatch sign as an imaging biomarker for IDH and 1p/19q status in diffuse low-grade gliomas: a systematic review with a Bayesian approach to evaluation of diagnostic test performance.
    Goyal A, Yolcu YU, Goyal A, Kerezoudis P, Brown DA, Graffeo CS, Goncalves S, Burns TC, Parney IF.
    Neurosurg Focus; 2019 Dec 01; 47(6):E13. PubMed ID: 31786548
    [Abstract] [Full Text] [Related]

  • 6. Prediction of IDH1-Mutation and 1p/19q-Codeletion Status Using Preoperative MR Imaging Phenotypes in Lower Grade Gliomas.
    Park YW, Han K, Ahn SS, Bae S, Choi YS, Chang JH, Kim SH, Kang SG, Lee SK.
    AJNR Am J Neuroradiol; 2018 Jan 01; 39(1):37-42. PubMed ID: 29122763
    [Abstract] [Full Text] [Related]

  • 7. Whole-Tumor Histogram and Texture Analyses of DTI for Evaluation of IDH1-Mutation and 1p/19q-Codeletion Status in World Health Organization Grade II Gliomas.
    Park YW, Han K, Ahn SS, Choi YS, Chang JH, Kim SH, Kang SG, Kim EH, Lee SK.
    AJNR Am J Neuroradiol; 2018 Apr 01; 39(4):693-698. PubMed ID: 29519794
    [Abstract] [Full Text] [Related]

  • 8. RNA editing-based classification of diffuse gliomas: predicting isocitrate dehydrogenase mutation and chromosome 1p/19q codeletion.
    Chen SC, Lo CM, Wang SH, Su EC.
    BMC Bioinformatics; 2019 Dec 24; 20(Suppl 19):659. PubMed ID: 31870275
    [Abstract] [Full Text] [Related]

  • 9. MRI Features Can Predict 1p/19q Status in Intracranial Gliomas.
    Lasocki A, Gaillard F, Gorelik A, Gonzales M.
    AJNR Am J Neuroradiol; 2018 Apr 24; 39(4):687-692. PubMed ID: 29519793
    [Abstract] [Full Text] [Related]

  • 10. Non-invasive genotype prediction of chromosome 1p/19q co-deletion by development and validation of an MRI-based radiomics signature in lower-grade gliomas.
    Han Y, Xie Z, Zang Y, Zhang S, Gu D, Zhou M, Gevaert O, Wei J, Li C, Chen H, Du J, Liu Z, Dong D, Tian J, Zhou D.
    J Neurooncol; 2018 Nov 24; 140(2):297-306. PubMed ID: 30097822
    [Abstract] [Full Text] [Related]

  • 11. Impact of 1p/19q codeletion status on extent of resection in WHO grade II glioma: Insights from a national cancer registry.
    Lu VM, Alvi MA, Bydon M, Quinones-Hinojosa A, Chaichana KL.
    Clin Neurol Neurosurg; 2019 Jul 24; 182():32-36. PubMed ID: 31063969
    [Abstract] [Full Text] [Related]

  • 12. MRI radiomics analysis of molecular alterations in low-grade gliomas.
    Shofty B, Artzi M, Ben Bashat D, Liberman G, Haim O, Kashanian A, Bokstein F, Blumenthal DT, Ram Z, Shahar T.
    Int J Comput Assist Radiol Surg; 2018 Apr 24; 13(4):563-571. PubMed ID: 29270916
    [Abstract] [Full Text] [Related]

  • 13. MRI and CT Identify Isocitrate Dehydrogenase (IDH)-Mutant Lower-Grade Gliomas Misclassified to 1p/19q Codeletion Status with Fluorescence in Situ Hybridization.
    Patel SH, Batchala PP, Mrachek EKS, Lopes MS, Schiff D, Fadul CE, Patrie JT, Jain R, Druzgal TJ, Williams ES.
    Radiology; 2020 Jan 24; 294(1):160-167. PubMed ID: 31714193
    [No Abstract] [Full Text] [Related]

  • 14. Determining chromosomal arms 1p/19q co-deletion status in low graded glioma by cross correlation-periodogram pattern analysis.
    Bhattacharya D, Sinha N, Saini J.
    Sci Rep; 2021 Dec 13; 11(1):23866. PubMed ID: 34903768
    [Abstract] [Full Text] [Related]

  • 15. Cystathionine as a marker for 1p/19q codeleted gliomas by in vivo magnetic resonance spectroscopy.
    Branzoli F, Pontoizeau C, Tchara L, Di Stefano AL, Kamoun A, Deelchand DK, Valabrègue R, Lehéricy S, Sanson M, Ottolenghi C, Marjańska M.
    Neuro Oncol; 2019 Jun 10; 21(6):765-774. PubMed ID: 30726924
    [Abstract] [Full Text] [Related]

  • 16. Neuroimaging-Based Classification Algorithm for Predicting 1p/19q-Codeletion Status in IDH-Mutant Lower Grade Gliomas.
    Batchala PP, Muttikkal TJE, Donahue JH, Patrie JT, Schiff D, Fadul CE, Mrachek EK, Lopes MB, Jain R, Patel SH.
    AJNR Am J Neuroradiol; 2019 Mar 10; 40(3):426-432. PubMed ID: 30705071
    [Abstract] [Full Text] [Related]

  • 17. Amide proton transfer weighted and diffusion weighted imaging based radiomics classification algorithm for predicting 1p/19q co-deletion status in low grade gliomas.
    Ma A, Yan X, Qu Y, Wen H, Zou X, Liu X, Lu M, Mo J, Wen Z.
    BMC Med Imaging; 2024 Apr 10; 24(1):85. PubMed ID: 38600452
    [Abstract] [Full Text] [Related]

  • 18. Radiological characteristics based on isocitrate dehydrogenase mutations and 1p/19q codeletion in grade II and III gliomas.
    Yamauchi T, Ohno M, Matsushita Y, Takahashi M, Miyakita Y, Kitagawa Y, Kondo E, Tsushita N, Satomi K, Yoshida A, Ichimura K, Narita Y.
    Brain Tumor Pathol; 2018 Jul 10; 35(3):148-158. PubMed ID: 29922974
    [Abstract] [Full Text] [Related]

  • 19. Static and dynamic 18F-FET PET for the characterization of gliomas defined by IDH and 1p/19q status.
    Verger A, Stoffels G, Bauer EK, Lohmann P, Blau T, Fink GR, Neumaier B, Shah NJ, Langen KJ, Galldiks N.
    Eur J Nucl Med Mol Imaging; 2018 Mar 10; 45(3):443-451. PubMed ID: 29043400
    [Abstract] [Full Text] [Related]

  • 20. Correlation between chromosome 1p/19q status and VEGF mRNA expression in gliomas.
    Yang B, Hao XQ, Zeng XW, Ji TL, Pan S, Feng YG.
    Genet Mol Res; 2016 Jan 26; 15(1):. PubMed ID: 26909925
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.